Table 2 Correlation of BIRC5 and SKP2 expression levels of liver control tissues with cirrhosis or hepatitis in the TMA cohort.
From: Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma
A. BIRC5 expression levels of liver control tissues in the TMA cohort | |||
|---|---|---|---|
Clinicopathological features | Low expression of BIRC5 | High expression of BIRC5 | p |
Cirrhosis history | 0.769 | ||
No | 20 (28.6%) | 4 (22.2%) | |
Yes | 50 (71.4%) | 14 (77.8%) | |
Hepatitis history | 0.544 | ||
No | 15 (21.4%) | 5 (27.8%) | |
Yes | 55 (78.6%) | 13 (72.2%) | |
B. SKP2 expression levels of liver control tissues in the TMA cohort | |||
|---|---|---|---|
Clinicopathological features | Low expression of SKP2 | High expression of SKP2 | p |
Cirrhosis history | 0.042 | ||
No | 14 (38.9%) | 10 (19.2%) | |
Yes | 22 (61.1%) | 42 (80.8%) | |
Hepatitis history | 0.672 | ||
No | 9 (25.0%) | 11 (21.2%) | |
Yes | 27 (75.0%) | 41 (78.8%) | |
